Adagene (ADAG) Debt Ratio (2019 - 2025)

Adagene's (ADAG) quarterly Debt Ratio came in at 23632.19 in Q4 2025, down 84.19% year-on-year from 149447.44 in Q4 2024, and up 34624091.57% on a QoQ basis from 0.07 in Q2 2025.

Adagene (ADAG) Debt Ratio (2019 - 2025) Analysis & Trends

Adagene (ADAG) has 7 years of Debt Ratio data on file, last reported at 23632.19 in Q4 2025.

  • On a quarterly basis, Debt Ratio fell 84.19% year-over-year to 23632.19 in Q4 2025; TTM through Dec 2025 was 23632.19, a 84.19% decrease from a year earlier, with the FY2025 full-year figure at 23632.19, down 84.19% from the prior year.
  • Debt Ratio for Q4 2025 stood at 23632.19, up from 0.07 in the prior quarter.
  • Over the last five years, Debt Ratio for ADAG reached as high as 117831516847.35 in Q2 2023 and fell as low as 0.02 in Q2 2021.
  • Historically, Debt Ratio has averaged 17726682365.07 across 5 years, with a median of 67579.5 in 2025.
  • Across the five-year window, Debt Ratio soared 339004139106671.8% in 2022 and tumbled 100.0% in 2024, its largest moves.
  • Year by year, Debt Ratio stood at 0.02 in 2021, then soared by 630762979.9% to 111526.81 in 2022, then jumped by 37.15% to 152957.41 in 2023, then decreased by 2.29% to 149447.44 in 2024, then tumbled by 84.19% to 23632.19 in 2025.
  • Per Business Quant data, the three most recent Debt Ratio figures were 23632.19 in Q4 2025, 0.07 in Q2 2025, and 149447.44 in Q4 2024.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Debt Ratio (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - -
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - 1.41
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn 0.11
4 NuCana 279.75 Bn 279.75 Bn - -
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn -
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn 0.05
7 Belite Bio 62.51 Bn 62.51 Bn - -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn -
9 Revolution Medicines 37.78 Bn 37.78 Bn - -
10 Adagene 198.85 Mn 198.85 Mn - 23,632.19

Historic Data

Download Data
DateValue
Dec 31, 2025 23,632.19
Jun 30, 2025 0.07
Dec 31, 2024 149,447.44
Jun 30, 2024 0.16
Dec 31, 2023 152,957.41
Jun 30, 2023 117.83 Bn
Dec 31, 2022 111,526.81
Jun 30, 2022 59.43 Bn
Dec 31, 2021 0.02
Jun 30, 2021 0.02
Dec 31, 2020 0.07
Dec 31, 2019 0.02